Back to Ovarian Cancer
NCT01697488
NCT01697488
Who may be able to join
Who might be able to join this trial:
- For phase 1 of the study: you must be 18 years old or older
- For phase 2 of the study: you must be 70 years old or older
- You have been recently diagnosed with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (a cancer affecting the lining of the abdomen) for the first time, and your doctors have recommended a specific chemotherapy treatment combining carboplatin, paclitaxel, and a drug called Avastin (bevacizumab)
Who may not be able to join:
- You have a medical reason why you should not take Avastin, based on the official guidelines for that medication (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Hoffmann-La Roche
Registry
clinicaltrials_gov
Start date
2 February 2012
Est. completion
27 September 2019
Where this trial is recruiting
🇩🇪 Germany
Primary endpoints
Efficacy: Progression-free survival; Safety: Incidence of adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.